相关实验视频
Updated: Feb 28, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.5K
强化长效眼膜凝装载纳米配方德克萨米他用于干眼治疗
Aya A Refaat1, Sarah Yahia1, Ibrahim M El-Sherbiny2
1Nanomedicine Research Laboratories, Center for Materials Science (CMS), Zewail City of Science and Technology, 6Th of October, 12578, Giza, Egypt.
AAPS PharmSciTech
|February 25, 2026
概括
这项研究开发了一种用于治疗干眼病 (DED) 的新型长效眼凝,使用纳米配制的甲甲 (DEX) 在氨酸 (HA) 基质中. 在大鼠模型中,增强的配方证明了持续的药物释放和改善的角膜结构.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术 纳米技术
- 药品制造 药品制造 药品制造
背景情况:
- 干眼病 (DED) 对传统的眼部药物输送提出了重大挑战,原因是生物可用性差和快速消除.
- 现有的治疗方法往往需要频繁的使用,这会影响患者的服药性和治疗效果.
研究的目的:
- 开发一种强化,长效的眼凝,用于DED治疗,通过结合纳米配方德克萨米 (DEX).
- 通过修改人工眼配方以氨酸 (HA) 和DEX载荷纳米粒子 (DEX-NPs) 来增强药物输送.
主要方法:
- 优化DEX-NPs的配方使用一个3^1.1. 2^2的因数实验设计.
- 通过动态光散射 (DLS) 和传输电子显微镜 (TEM) 来描述DEX-NP的形态和大小.
- 使用干眼鼠模型和角膜结构组织学分析评估体内疗效.
主要成果:
- 优化DEX-NP的粒子大小为250 ± 3 nm.
- 从DEX-NP中持续释放DEX的时间约为5天.
- 新型DEX-NPs-in-HA@in-situ凝与未经修改的商业眼凝相比,显示出角膜结构的显著改善.
结论:
- 开发的纳米配方DEX载荷眼凝为DED治疗提供了一个有前途的持续释放系统.
- 这种增强的药物递送系统显示了改善眼睛表面健康和减少药物递送频率的潜力.
相关概念视频
Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K

